PROCELL BIOLOGICS

Procell Biologics was established in 2021 with the intent to be a hub for the development and manufacture of biologic products for the domestic and international markets. Our biosimilars address metabolic disorders, inflammatory diseases, and various types of cancer. We also have built capabilities for both biosimilar and biotherapeutic research. We envisage extending our services to CDMO activities by end-2024... At our state-of-the-art, 11,000 sft R&D facility at MN Park, Genome Valley, Hyderabad, we develop and deliver processes for microbial and mammalian products from vial to drug products including analytical method development, verification and validation. We adhere to quality documentation to meet the latest regulatory requirements.

Also known as: Procell Biologics Pvt. Ltd.

Primary location: Hyderabad India